2grq

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="2grq" size="450" color="white" frame="true" align="right" spinBox="true" caption="2grq, resolution 1.700&Aring;" /> '''Crystal Structure ...)
Line 1: Line 1:
-
[[Image:2grq.gif|left|200px]]<br />
+
[[Image:2grq.gif|left|200px]]<br /><applet load="2grq" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="2grq" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="2grq, resolution 1.700&Aring;" />
caption="2grq, resolution 1.700&Aring;" />
'''Crystal Structure of human RanGAP1-Ubc9-D127A'''<br />
'''Crystal Structure of human RanGAP1-Ubc9-D127A'''<br />
==Overview==
==Overview==
-
E2 conjugating proteins that transfer ubiquitin and ubiquitin-like, modifiers to substrate lysine residues must first activate the lysine, nucleophile for conjugation. Genetic complementation revealed three side, chains of the E2 Ubc9 that were crucial for normal growth. Kinetic, analysis revealed modest binding defects but substantially lowered, catalytic rates for these mutant alleles with respect to wild-type Ubc9., X-ray structures for wild-type and mutant human Ubc9-RanGAP1 complexes, showed partial loss of contacts to the substrate lysine in mutant, complexes. Computational analysis predicted pK perturbations for the, substrate lysine, and Ubc9 mutations weakened pK suppression through, improper side chain coordination. Biochemical studies with p53, RanGAP1, and the Nup358/RanBP2 E3 were used to determine rate constants and pK, values, confirming both structural and computational predictions. It seems, that Ubc9 uses an indirect mechanism to activate lysine for conjugation, that may be conserved among E2 family members.
+
E2 conjugating proteins that transfer ubiquitin and ubiquitin-like modifiers to substrate lysine residues must first activate the lysine nucleophile for conjugation. Genetic complementation revealed three side chains of the E2 Ubc9 that were crucial for normal growth. Kinetic analysis revealed modest binding defects but substantially lowered catalytic rates for these mutant alleles with respect to wild-type Ubc9. X-ray structures for wild-type and mutant human Ubc9-RanGAP1 complexes showed partial loss of contacts to the substrate lysine in mutant complexes. Computational analysis predicted pK perturbations for the substrate lysine, and Ubc9 mutations weakened pK suppression through improper side chain coordination. Biochemical studies with p53, RanGAP1 and the Nup358/RanBP2 E3 were used to determine rate constants and pK values, confirming both structural and computational predictions. It seems that Ubc9 uses an indirect mechanism to activate lysine for conjugation that may be conserved among E2 family members.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
2GRQ is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Active as [http://en.wikipedia.org/wiki/Ubiquitin--protein_ligase Ubiquitin--protein ligase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=6.3.2.19 6.3.2.19] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2GRQ OCA].
+
2GRQ is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Active as [http://en.wikipedia.org/wiki/Ubiquitin--protein_ligase Ubiquitin--protein ligase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=6.3.2.19 6.3.2.19] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2GRQ OCA].
==Reference==
==Reference==
Line 18: Line 17:
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Ubiquitin--protein ligase]]
[[Category: Ubiquitin--protein ligase]]
-
[[Category: Lima, C.D.]]
+
[[Category: Lima, C D.]]
-
[[Category: Yunus, A.A.]]
+
[[Category: Yunus, A A.]]
[[Category: conjugation]]
[[Category: conjugation]]
[[Category: small ubiquitin like modifer]]
[[Category: small ubiquitin like modifer]]
Line 25: Line 24:
[[Category: ubiquitin]]
[[Category: ubiquitin]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 22:21:42 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:34:37 2008''

Revision as of 15:34, 21 February 2008


2grq, resolution 1.700Å

Drag the structure with the mouse to rotate

Crystal Structure of human RanGAP1-Ubc9-D127A

Contents

Overview

E2 conjugating proteins that transfer ubiquitin and ubiquitin-like modifiers to substrate lysine residues must first activate the lysine nucleophile for conjugation. Genetic complementation revealed three side chains of the E2 Ubc9 that were crucial for normal growth. Kinetic analysis revealed modest binding defects but substantially lowered catalytic rates for these mutant alleles with respect to wild-type Ubc9. X-ray structures for wild-type and mutant human Ubc9-RanGAP1 complexes showed partial loss of contacts to the substrate lysine in mutant complexes. Computational analysis predicted pK perturbations for the substrate lysine, and Ubc9 mutations weakened pK suppression through improper side chain coordination. Biochemical studies with p53, RanGAP1 and the Nup358/RanBP2 E3 were used to determine rate constants and pK values, confirming both structural and computational predictions. It seems that Ubc9 uses an indirect mechanism to activate lysine for conjugation that may be conserved among E2 family members.

Disease

Known diseases associated with this structure: Blood group, Cad system OMIM:[111730], Blood group, Sd system OMIM:[111730]

About this Structure

2GRQ is a Protein complex structure of sequences from Homo sapiens. Active as Ubiquitin--protein ligase, with EC number 6.3.2.19 Full crystallographic information is available from OCA.

Reference

Lysine activation and functional analysis of E2-mediated conjugation in the SUMO pathway., Yunus AA, Lima CD, Nat Struct Mol Biol. 2006 Jun;13(6):491-9. Epub 2006 May 28. PMID:16732283

Page seeded by OCA on Thu Feb 21 17:34:37 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools